This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bernstein, D. I. Articles by Lummus, Z. Search for Related Content PubMed PubMed Citation Articles by Bernstein, D. I. Articles by Lummus, Z.

Diisocyanate Antigen-stimulated Monocyte Chemoattractant Protein-1 Synthesis Has Greater Test Efficiency than Specific Antibodies for Identification of Diisocyanate Asthma

Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio; Laboratoire de Pneumologie-Researche, Hôpital du Sacré Coeur de Montreal, Montreal; and Institut de Cardiologie et de Pneumologie de L'Université Laval, Hôpital Laval, Sainte-Foy, Québec, Canada

Correspondence and requests for reprints should be addressed to David I. Bernstein, MD, University of Cincinnati College of Medicine, Department of Internal Medicine, Division of Immunology, 231 Albert Sabin Way, Cincinnati, OH 45267-0563. E-mail: bernstdd{at}email.uc.edu

We previously reported that diisocyanate-human serum albumin (DIISO-HSA) stimulated production of monocyte chemoattractant protein-1 (MCP-1) by peripheral blood mononuclear cells is significantly associated with a clinical diagnosis of diisocyanate asthma (DA). Others have reported that antibodies for DIISO-HSA are specific but insensitive markers of DA. This study was performed to evaluate test characteristics of the in vitro MCP-1 assay compared with DIISO-HSA–specific immunoglobulin (Ig) G and IgE in identifying workers with DA. MCP-1 was quantitated in peripheral blood mononuclear cell supernatants 48 hours after incubation with DIISO-HSA antigens. Assay results were compared with outcomes of specific inhalation challenge (SIC) testing. Nineteen of 54 (35%) workers assayed for antibodies and MCP-1 stimulation had SIC-confirmed DA. Mean MCP-1 produced by SIC-positive workers was greater than SIC-negative workers (p 0.001). Diagnostic sensitivity, specificity, and test efficiency for specific IgG were 47%, 74%, and 65%, respectively, and for specific IgE were 21%, 89%, and 65%, respectively. Sensitivity, specificity, and test efficiency of the MCP-1 test were 79%, 91%, and 87%, respectively. This study indicates that the MCP-1 stimulation assay has greater sensitivity and specificity than the specific antibody assays in correctly identifying DA.

Key Words: occupational asthma • diisocyanate • MCP-1 • antibody

This article has been cited by other articles:

				S. M. Tarlo, J.-L. Malo, and on behalf of the Third Jack Pepys Workshop on Asth An Official ATS Proceedings: Asthma in the Workplace: The Third Jack Pepys Workshop on Asthma in the Workplace: Answered and Unanswered Questions Proceedings of the ATS, August 1, 2009; 6(4): 339 - 349. [Abstract] [Full Text] [PDF]

				S. M. Tarlo, J. Balmes, R. Balkissoon, J. Beach, W. Beckett, D. Bernstein, P. D. Blanc, S. M. Brooks, C. T. Cowl, F. Daroowalla, et al. Diagnosis and Management of Work-Related Asthma: American College of Chest Physicians Consensus Statement Chest, September 1, 2008; 134(3_suppl): 1S - 41S. [Abstract] [Full Text] [PDF]

				A. K. Farraj, E. Boykin, N. Haykal-Coates, S. H. Gavett, D. Doerfler, and M. Selgrade Th2 Cytokines in Skin Draining Lymph Nodes and Serum IgE Do Not Predict Airway Hypersensitivity to Intranasal Isocyanate Exposure in Mice Toxicol. Sci., November 1, 2007; 100(1): 99 - 108. [Abstract] [Full Text] [PDF]

				M. P. Holsapple, D. Jones, T. T. Kawabata, I. Kimber, K. Sarlo, M. K. Selgrade, J. Shah, and M. R. Woolhiser Assessing the Potential to Induce Respiratory Hypersensitivity Toxicol. Sci., May 1, 2006; 91(1): 4 - 13. [Abstract] [Full Text] [PDF]

				S. M. Tarlo, J-L. Malo, and other Workshop members An ATS/ERS report: 100 key questions and needs in occupational asthma. Eur. Respir. J., March 1, 2006; 27(3): 607 - 614. [Abstract] [Full Text] [PDF]

				S. M. Tarlo Cough: Occupational and Environmental Considerations: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 186S - 196S. [Abstract] [Full Text] [PDF]

				C. E. Mapp, P. Boschetto, P. Maestrelli, and L. M. Fabbri Occupational Asthma Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 280 - 305. [Abstract] [Full Text] [PDF]

				J. M. Matheson, V. J. Johnson, and M. I. Luster Immune Mediators in a Murine Model for Occupational Asthma: Studies with Toluene Diisocyanate Toxicol. Sci., March 1, 2005; 84(1): 99 - 109. [Abstract] [Full Text] [PDF]

				A. K. Farraj, J. R. Harkema, and N. E. Kaminski Allergic Rhinitis Induced by Intranasal Sensitization and Challenge with Trimellitic Anhydride but Not with Dinitrochlorobenzene or Oxazolone in A/J Mice Toxicol. Sci., June 1, 2004; 79(2): 315 - 325. [Abstract] [Full Text] [PDF]

				J. Sastre, O. Vandenplas, and H-S. Park Pathogenesis of occupational asthma Eur. Respir. J., August 1, 2003; 22(2): 364 - 373. [Abstract] [Full Text] [PDF]

				G. Moscato, J-L. Malo, and D. Bernstein Diagnosing occupational asthma: how, how much, how far? Eur. Respir. J., May 1, 2003; 21(5): 879 - 885. [Abstract] [Full Text] [PDF]

				M. J. Tobin Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 319 - 332. [Full Text] [PDF]

				M. J. Tobin Tuberculosis, Lung Infections, Interstitial Lung Disease, and Journalology in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 345 - 355. [Full Text] [PDF]

				C. A. Redlich, A. V. Wisnewski, and T. Gordon Mouse Models of Diisocyanate Asthma Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 385 - 390. [Full Text] [PDF]

				D. J. Hendrick Diagnostic Tests for Occupational Asthma Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 436 - 437. [Full Text] [PDF]